Skip to main content

Table 2 Univariable analysis

From: A prospective study examining cachexia predictors in patients with incurable cancer

Univariable analysis

 

HR

95% CI

p

Age at inclusion

1.01

1.00–1.03

0.06

Gender

 Male

1.5

1.1–2.0

0.01

 Female

1

  

 Weight loss (6 months)

1.6

1.4–1.7

<  0.001

BMI

0.99

0.95–1.03

0.53

Karnofsky PS (0–100)

0.98

0.97–1.00

<  0.01

Fatigue (0–100)

1.00

1.00–1.01

0.26

Physical functioning (0–100)

0.99

0.99–1.00

0.09

Emotional functioning (0–100)

1.00

0.99–1.01

0.67

Food intake

 Less than usual

1.7

1.2–2.4

<  0.01

 More than usual

1.0

0.6–1.7

0.93

 Unchanged

1

  

Appetite loss (0–100)

1.01

1.01–1.02

<  0.001

Cancer stage

 Metastatic/disseminated

1.7

1.0–2.9

0.07

 Local

1

  

Cancer typea

 High risk cancer

4.4

2.4–8.1

<  0.001

 Neutral risk cancer

2.1

1.4–3.1

<  0.001

 Low risk cancer

1

  

Heart disease

0.9

0.6–1.3

0.55

Renal disease

1.4

0.6–3.1

0.45

Arthritis

1.4

0.8–2.3

0.22

COPD

1.7

1.1–2.7

0.02

  1. Abbreviations: HR hazard ratio, CI confidence interval, BMI body mass index, PS performance status, COPD chronic obstructive pulmonary disease
  2. aLow risk - Breast cancer, lymphoma, leukaemia; High risk – pancreatic and gastric cancer; Neutral risk - all other cancers